ClinicalTrials.Veeva

Menu

Tissue Sensor to Reduce the Need for Controlled Apnea During Retrograde Intrarenal Surgery

B

Botkin Hospital

Status

Not yet enrolling

Conditions

Tissue Sensor

Treatments

Procedure: RIRS with Tissue Sensor
Procedure: RIRS without Tissue Sensor

Study type

Interventional

Funder types

Other

Identifiers

NCT07851116
MoscowBotkinHospital3

Details and patient eligibility

About

Retrograde intrarenal surgery is an established minimally invasive treatment for renal stones. During laser lithotripsy, respiratory motion causes the kidney, renal collecting system, and stone to move relative to the distal tip of the laser fiber. This can impair precise fiber positioning, reduce operative-field stability, and increase the risk of unintended laser exposure of the urothelium of the renal collecting system.

To reduce respiratory motion of the kidney, the surgeon may ask the anesthesiologist to temporarily pause mechanical ventilation. Controlled apnea can briefly stabilize the operative field; however, it requires interruption of ventilation and may cause oxygen desaturation, carbon dioxide accumulation, hemodynamic changes, and increased anesthetic burden.

Tissue Sensor is a technology that automatically terminates laser emission when contact between the distal tip of the laser fiber and tissue is detected. Tissue Sensor is expected to reduce the risk of unintended laser exposure of the renal collecting-system mucosa during respiratory motion of the kidney.

Greater surgeon confidence in the safety of laser activation may reduce the need to stabilize the kidney with controlled apnea. At the same time, brief automatic interruptions of laser emission may increase lithotripsy time and total operative time.

Enrollment

130 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years or older.
  • A single renal stone.
  • An indication for elective RIRS.
  • Feasibility of performing the intervention with a flexible ureteroscope.
  • Recommended stone diameter on CT: 7-15 mm.
  • Stone located in a calyx, a group of calyces, or the renal pelvis.
  • Feasibility of TFL use.
  • General anesthesia with controlled mechanical ventilation.
  • No active urinary tract infection.
  • Ability to undergo low-dose non-contrast CT at 1 month.
  • Signed written informed consent.

Exclusion criteria

  • Multiple stones in the study kidney.
  • Complete or partial staghorn stone.
  • Ipsilateral ureteral stone.
  • Renal or upper urinary tract anomaly that substantially alters the anatomy.
  • Horseshoe, pelvic, or ectopic kidney.
  • Stone within a calyceal diverticulum.
  • Ureteral stricture.
  • Previous reconstructive surgery involving the study kidney or ureter.
  • Active infection, obstructive pyelonephritis, or urosepsis.
  • Nephrostomy drainage.
  • Pregnancy.
  • Severe respiratory failure or a contraindication to apnea.
  • Severe cardiovascular instability.
  • Inability to undergo general anesthesia.
  • Combined, bilateral, or percutaneous intervention.
  • Suspected upper urinary tract tumor.
  • Inability to comply with the study protocol.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

130 participants in 1 patient group

patients with a single renal stone who are scheduled for elective retrograde intrarenal surger
Experimental group
Description:
RIRS will be performed using a thulium fiber laser with Tissue Sensor activated. All automatic system trigger events will be recorded and, whenever possible, synchronized with the procedure video recording.
Treatment:
Procedure: RIRS without Tissue Sensor
Procedure: RIRS with Tissue Sensor

Trial contacts and locations

0

Loading...

Central trial contact

Vigen Malkhasyan, Doctor of Medical Sciences; Nikita Astakhov

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems